Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butantan-DV dengue vaccine effectiveness and safety after mass vaccination in Botucatu
RBR-6tmdrtgRecruiting
- Sponsor
- Ministério da Saúde
- Start
- Jan 2026
- Modality
- Live Attenuated Vaccines → Live Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Open-label trial of Butantan-DV in dengue fever (2 arms), sponsored by Ministério da Saúde. Primary endpoints: Dengue incidence effectiveness endpoint, Test-negative vaccine effectiveness endpoint and 3 more. Started Jan 2026; status: recruiting.
02
Drugs
Butantan-DV
03
Conditions
dengue fever
Beyond the preview
Go deeper on RBR-6tmdrtg.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6tmdrtg.